Dhaka, April 28 -- Eskayef Pharmaceuticals Ltd. and Novo Nordisk on Tuesday announced the start of local production of modern insulin cartridges in Bangladesh through technology transfer from Denmark.

The initiative will see cartridges, including NovoMix and NovoRapid, produced locally under a contract manufacturing arrangement, aiming to improve availability and reduce costs for diabetes patients, according to a press release.

Officials said premix and rapid-acting insulin cartridges would be manufactured in Bangladesh using Novo Nordisk's global technology, with each batch verified in Denmark to maintain quality standards.

Health ministry representative Sardar Shakhawat Hossain Bokul said the move would support access to essential me...